MedPath
TGA Approval

REMICADE infliximab 100mg powder for injection vial (73827)

73827

REMICADE infliximab 100mg powder for injection vial

Janssen-Cilag Pty Ltd

August 2, 2000

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-03024-3

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-03023-3

Active Ingredients

Infliximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REMICADE infliximab 100mg powder for injection vial (73827) - TGA 批准文号 | MedPath